An ANGPTL8‐AKT2‐mTOR Axis Drives Adipose Senescence and Aging‐Related Functional Decline
Aging Cell · 2026-08 · 25 (8)
DOI: 10.1111/acel.70671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 16.08.2026. Verfasst von Yi He und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt, Adipose Tissue, Aging. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Adipose tissue senescence is increasingly recognized as a key driver of systemic aging and age‐related functional decline, yet the endocrine regulators that actively promote this process remain poorly defined. Angiopoietin‐like protein 8 (ANGPTL8) is a metabolic factor implicated in lipid metabolism and inflammation and has been associated with multiple aging‐related disorders. However, its direct role in adipose tissue senescence and organismal aging remains unclear. Here, we identify ANGPTL8 as a previously unrecognized regulator of adipose tissue aging through integrative analyzes of human cohorts, animal models, transcriptomics, and cellular studies. In a large human cohort, circulating ANGPTL8 levels were strongly associated with biological aging and mortality risk and significantly improved machine learning–based models for age and survival prediction. Consistent with these findings, genetic deletion of Angptl8 in mice extended lifespan, attenuated aging‐associated functional decline, and reduced senescence markers in adipose tissue. Transcriptomic analyzes revealed age‐dependent upregulation of ANGPTL8 in adipocytes accompanied by activation of pro‐senescent transcriptional programs. Mechanistically, ANGPTL8 directly interacted with AKT2 and activated the AKT–mTOR–S6K signaling pathway, thereby promoting cell‐autonomous adipocyte senescence. Genetic or pharmacological inhibition of this pathway abolished the pro‐senescent effects of ANGPTL8. Collectively, our findings identify ANGPTL8 as an endocrine regulator linking metabolic dysfunction to adipose tissue senescence and systemic aging, highlighting the ANGPTL8–AKT2–mTOR axis as a potential therapeutic target for delaying age‐associated functional decline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Hubei Provincial Clinical Medical Research Center for Endocrinology and Metabolic Diseases, Wuhan, Hubei, China.
- Department of Metabolic and Bariatric Surgery, The Third Xiangya Hospital, Central South University, Changsha, China.
- Department of Joint Bone Disease Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.
ORCID-Profile: Yi He, Yaming Guo, Ranran Kan, Xuefeng Yu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
He, Y., Pan, L., Ping, W., Meng, C., Meng, X., Guo, Y., Kan, R., Xiang, Y., Mao, B., Wang, S., Li, D., & Yu, X. (2026). An ANGPTL8‐AKT2‐mTOR Axis Drives Adipose Senescence and Aging‐Related Functional Decline. Aging Cell, 25(8). https://doi.org/10.1111/acel.70671
Vancouver
He Y, Pan L, Ping W, Meng C, Meng X, Guo Y, et al. An ANGPTL8‐AKT2‐mTOR Axis Drives Adipose Senescence and Aging‐Related Functional Decline. Aging Cell. 2026;25(8). doi:10.1111/acel.70671
BibTeX
@article{He2026,
author = {He, Yi and Pan, Limeng and Ping, WenJun and Meng, Chen and Meng, Xiaoyu and Guo, Yaming and Kan, Ranran and Xiang, Yuxi and Mao, Beibei and Wang, Siyi and Li, Danpei and Yu, Xuefeng},
title = {An ANGPTL8‐AKT2‐mTOR Axis Drives Adipose Senescence and Aging‐Related Functional Decline},
journal = {Aging Cell},
year = {2026},
volume = {25},
number = {8},
doi = {10.1111/acel.70671}
}
EUVIMED